The European project VAX4ASF —New Technologies for African Swine Fever (ASF)— begins with the aim of developing a next-generation vaccine against ASF virus, finding a means to eradicating the disease globally.

The project, supported by the EU Horizon Europe program, is led by HIPRA and formed by an international consortium of 17 partners.

The goal of VAX4ASF is to provide a definitive, effective, and safe solution against the highly contagious, unpredictable, and complex ASF virus that affects pigs and wild boars, causing high mortality among the affected animals. The project aims to innovate based on previous vaccination approaches and strategies with the potential for success.